SENS May 2024 0.500 call

OPR - OPR Delayed price. Currency in USD

Add to watchlist

0.0100

-0.0200

(-66.67%)

At close: 01:23PM EDT

Loading interactive chart…

Zacks
Senseonics' (SENS) Deal With Mercy to Drive Eversense CGM Sales
Senseonics Holdings (SENS) collaborates with Mercy to bring its Eversense CGM to a healthcare system that is likely to drive its adoption.
GuruFocus.com
Senseonics Holdings Inc (SENS) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
Despite a net loss, Senseonics reports revenue growth and significant strategic collaborations in the first quarter of 2024.
Business Wire
Senseonics Holdings, Inc. Reports First Quarter 2024 Financial Results
GERMANTOWN, Md., May 13, 2024--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today reported financial results for the quarter ended March 31, 2024.